COMISSÃO DE SAÚDE

Thank you. Thank you. Well, after so many words, so many suggestions here, I think... I think a point very important in this whole process, deputada, is that in this search for a better way of treating patients from the point of view of the ocular health, is to look at cost-effective. I think that the cost-effective cost-effective is one of the most important things with so much technology that we have today. Right. so as countries like the United States, which is very rich, look for this path, I think that the Brazil also needs to look at cost-effective. There are several studies We have national studies showing, you mentioned about the Colírios Program. There are two important studies published by the USP and the UNIFESP, "Custo-efetividade da Trabéculopastia Seletiva em relação ao uso de medicamentos" e eu convido a todos a buscar esses artigos. I can even offer them, but I think it's important to have this reflection on the cost-effective treatment of the treatment, talking about glaucoma. and also extending this to other eye-coded patients. Thank you. Thank you.